Does a gluten shake or a gluten cookie produce a stronger immune response in celiac disease?
Official title: Assessing Immune Responses to Gluten: A Comparative Study of Liquid Versus Solid Gluten Administration
Run by Oslo University Hospital · NCT07039773 · Data updated 2026-11-12
This trial tests whether a liquid gluten shake or a solid gluten cookie causes a bigger IL-2 immune response in adults with celiac disease who have been on a gluten-free diet.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Oslo University Hospital Academic / other |
| Locations | 2 sites (Oslo, Oslo and 1 other locations) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | April 17, 2026 |
| Trial ID | NCT07039773 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with a prior biopsy-confirmed diagnosis of celiac disease who have adhered to a strict gluten-free diet for at least 12 months, have BMI 18–33 kg/m2, and meet the study screening labs and safety criteria are ideal candidates.
✕Probably not a fit
People with ongoing positive celiac serology, active inflammatory or systemic illnesses, pregnant or breastfeeding women, children, or those unable to attend the Oslo clinic visits are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with biopsy-proven celiac disease who have followed a strict gluten-free diet will undergo two supervised gluten challenges — one with a liquid shake and one with a solid cookie — given in randomized order at least four weeks apart. Blood samples will be collected before and after each challenge to measure serum IL-2 and gluten peptide concentrations over time. The study compares the magnitude and timing of the IL-2 cytokine response between the two formulations to see if one elicits a stronger or faster immune signal. Findings will inform which gluten formulation is most sensitive for provoking measurable immune responses in controlled challenge settings.
Why it matters
Potential benefit: If successful, the results could help standardize gluten-challenge methods and improve detection of immune responses in celiac disease, which may speed research and improve monitoring.
How similar studies have gone: Previous gluten challenge studies have shown rapid, measurable IL-2 rises after gluten exposure, so this work builds on existing findings but specifically compares liquid versus solid formulations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * BMI 18-33 kg/m2 * Willingness to comply with the study procedure and having signed informed, written consent * Previous diagnosis of coeliac disease according to established guidelines based on positive serology (Endomysium test, IgA-TG2 and/or IgG-DGP) (diagnosed in childhood) and a duodenal biopsy showing villous atrophy graded as Marsh 3 according to guidelines from European Society for Study of Coeliac Disease . * Strict adherence to a gluten-free diet at least the 12 last months. Exclusion Criteria: * Positive serology (IgA-TG2 below upper level of normal) at screening visit * Pregnancy or breast feeding. Fertile women must use effective contraception. * Other inflammatory disease like uncontrolled hypothyreosis, type 1 diabetes, cardiovascular diseases, thyroid and renal disorders, inflammatory bowel diseases or any other disease that in the opinion of the responsible clinician makes the patient unsuitable for the study * Using of immunosuppressive/steroid medications * Wheat allergy * Severe acute infection
Where it's running
-
Oslo University Hospital
Oslo, Oslo, Norway Recruiting -
Lovisenberg Diakonale Hospital
Oslo, Oslo, Norway Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mediterranean diet and processed food in adults with celiac disease on a gluten-free diet
This observational study looks at whether following a Mediterranean-style diet or eating more highly processed foods affects GI symptoms and quality of life in adults with celiac disease who have been on a strict gluten-free diet.
-
Exercise for Metabolic Syndrome and Fatty Liver in Adolescent Girls with Celiac Disease
This study tests whether a 3-month walking program helps improve metabolic syndrome and fatty liver in adolescent females with celiac disease.
-
Nutrition and physical activity education for children with celiac disease
This study tests whether a combined nutrition and physical activity education program helps 8- to 12-year-olds with celiac disease improve body health, eating habits, activity, and quality of life while on a gluten-free diet.
-
Liver Fat and Scarring in People Suspected of Non-Celiac Wheat Sensitivity
This study looks to see if people with non-celiac wheat sensitivity have liver fat or fibrosis and how this relates to IBS/FD and celiac disease.
-
Omega-3 fats to reduce inflammation in adults with newly diagnosed celiac disease
This study tests whether adding omega-3 fatty acid supplements to a gluten-free plan helps reduce inflammation and promote intestinal healing in adults who have just been diagnosed with celiac disease.
-
Wheat sensitivity or IBS/functional dyspepsia in relatives of people with celiac disease
This project will test whether adults related to celiac patients have higher rates of non-celiac wheat sensitivity or IBS/functional dyspepsia and whether symptoms change on a wheat-free diet.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.